𝔖 Bobbio Scriptorium
✦   LIBER   ✦

No-carrier-added synthesis of meta-[131I]iodobenzylguanidine

✍ Scribed by Ganesan Vaidyanathan; Michael R. Zalutsky


Book ID
103989291
Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
806 KB
Volume
44
Category
Article
ISSN
0969-8043

No coin nor oath required. For personal study only.

✦ Synopsis


No-carrier-added meta-[131I]iodobenzylguanidine ([131I]MIBG) was prepared starting with two different metallated precursors. Attempted preparation of 3-(tri-n-butylstannyl)benzylguanidine was not successful. An alternate two-step strategy using 3-(tri-n-butylstannyl)benzylamine could be used to prepare radio-iodinated [131I]MIBG in an overall radiochemical yield of 30-33%. Synthesis of [131I]MIBG via the radioiododesilylation of 3-trimethylsilylbenzylguanidine was also investigated. Yields were dependent on temperature, precursor concentration, solvent and nature of the oxidant. Radiochemical yields of 90% were obtained in 5 min at room temperature using either N-chlorosuccinimide or hydrogen peroxide in trifluoroacetic acid as oxidants. The percentage of specific binding in vitro of no-carrier-added MIBG to SK-N-SH neuroblastoma cells remained constant over a 2 log activity range, while the binding of MIBG prepared by isotopic exchange dropped by a factor of seven. In normal mice, heart and adrenal uptake of no-carrier-added [131I]MIBG was found to be higher than that of [131I]MIBG prepared by isotopic exchange.


πŸ“œ SIMILAR VOLUMES


Treatment of advanced neuroblastoma with
✍ Alberto Garaventa; Dr. Bruno De Bernardi; Edoardo Lanino; Paolo Guerra; Mario Be πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 635 KB

31 children with advanced pretreated neuroblastoma were treated with 131-1 meta-Iodobenzylguanidine (131-MIBG). Thirteen children had been resistant to first-line therapy, three had suffered a local relapse, and fourteen had suffered a disseminated relapse without overt bone marrow infiltration. On

Toxicity from treatment of neuroblastoma
✍ James C. Sisson; Raymond J. Hutchinson; James E. Carey; Brahm Shapiro; Jon W. Jo πŸ“‚ Article πŸ“… 1988 πŸ› Springer 🌐 English βš– 415 KB

Toxic effects from 131I-meta-iodobenzylguanidine (131I-MIBG) treatments of neuroblastoma in six patients were recorded. The toxicity was largely confined to the hematologic system where circulating leukocytes and platelets regularly declined after each dose of 131I-MIBG; the values reached nadirs be